Uncertainty of pregnant women living with HIV on antiretroviral treatment

Objective: determine the level of uncertainty of HIV pregnant women in antiretroviral therapy and their relationship to the variables age, occupation, marital status, years of study and weeks of gestation. The experience of living with HIV confronts the individual with certain complex situations or processes, where psychosocial implications may arise. For its part, pregnancy with HIV has been described as an experience governed by fear and uncertainty related to the risk of infection and the effect of antiretrovirals on the unborn child, which could represent a risk to physical health and emotional of the dyad. Materials and Methods: observational, descriptive study with an analytical component. The population consisted of all pregnant women diagnosed with HIV and antiretroviral treatment, who attended a check-up at an IPS in the city of Monteria (Fourteen). Results: 65% of pregnant women with HIV, on antiretroviral treatment, presented a high level of global uncertainty, 14% regular and 21% low. Conclusion: the pregnant women with HIV in antiretroviral therapy participating in the study presented a high level of uncertainty, especially regarding the prognosis, treatment and diagnosis. Of the variables analyzed, the relationship of uncertainty with age and weeks of gestation was evident.